1)日本高血圧学会高血圧治療ガイドライン作成委員会(編):高血圧治療ガイドライン2014(JSH2014),日本高血圧学会,ライフサイエンス出版,2014
2)Frans H, et al:β-Blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease. Arch Intern Med 170:880-887, 2010
3)日本腎臓学会:CKD診療ガイドライン2013, pp 49-51,東京医学社,2013
4)Lamberts M, et al:Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. J Am Coll Cardiol 62:981-989, 2013
5)European Heart Rhythm Association;European Association for Cardio Thoracic Surgery, Camm AJ, et al:Guidelines for the management of atrial fibrillation:the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology(ESC). Eur Heart J 31:2369-2429, 2010
6)Toyoda K, et al:Blood pressure levels and bleeding events during antithrombotic therapy;The Bleeding with Antithrombotic Therapy(BAT)Study. Stroke 41:1440-1444, 2010